233 related articles for article (PubMed ID: 30225213)
1. Inherited lung cancer syndromes targeting never smokers.
Yamamoto H; Yatabe Y; Toyooka S
Transl Lung Cancer Res; 2018 Aug; 7(4):498-504. PubMed ID: 30225213
[TBL] [Abstract][Full Text] [Related]
2. Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations.
Gazdar A; Robinson L; Oliver D; Xing C; Travis WD; Soh J; Toyooka S; Watumull L; Xie Y; Kernstine K; Schiller JH
J Thorac Oncol; 2014 Apr; 9(4):456-63. PubMed ID: 24736066
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.
Shigematsu H; Takahashi T; Nomura M; Majmudar K; Suzuki M; Lee H; Wistuba II; Fong KM; Toyooka S; Shimizu N; Fujisawa T; Minna JD; Gazdar AF
Cancer Res; 2005 Mar; 65(5):1642-6. PubMed ID: 15753357
[TBL] [Abstract][Full Text] [Related]
4. Screening for germline EGFR T790M mutations through lung cancer genotyping.
Oxnard GR; Miller VA; Robson ME; Azzoli CG; Pao W; Ladanyi M; Arcila ME
J Thorac Oncol; 2012 Jun; 7(6):1049-52. PubMed ID: 22588155
[TBL] [Abstract][Full Text] [Related]
5. Germline EGFR mutations in lung cancer (Review).
Liu M; Niu X; Liu H; Chen J
Oncol Lett; 2023 Jul; 26(1):282. PubMed ID: 37274482
[TBL] [Abstract][Full Text] [Related]
6. Identification of the Unique Clinical and Genetic Features of Chinese Lung Cancer Patients With
Lin X; Peng M; Chen Q; Yuan M; Chen R; Deng H; Deng J; Liu O; Weng Y; Chen M; Zhou C
Front Oncol; 2021; 11():774156. PubMed ID: 34869019
[TBL] [Abstract][Full Text] [Related]
7. EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer.
Lu S; Yu Y; Li Z; Yu R; Wu X; Bao H; Ding Y; Shao YW; Jian H
J Thorac Oncol; 2019 Apr; 14(4):732-736. PubMed ID: 30610926
[TBL] [Abstract][Full Text] [Related]
8. Familial rare EGFR-mutant lung cancer syndrome: Review of literature and description of R776H family.
Gabriel L; McVeigh T; Macmahon S; Avila Z; Donovan L; Hunt I; Draper A; Minchom A; Popat S; Davidson M; Bhosle J; Milner Watts C; Hubank M; Yuan L; O'Brien M
Lung Cancer; 2024 May; 191():107543. PubMed ID: 38569279
[TBL] [Abstract][Full Text] [Related]
9. Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.
Zhang W; Stabile LP; Keohavong P; Romkes M; Grandis JR; Traynor AM; Siegfried JM
J Thorac Oncol; 2006 Sep; 1(7):635-47. PubMed ID: 17409930
[TBL] [Abstract][Full Text] [Related]
10. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Potential of Afatinib for Cancers with
Yamamoto H; Toyooka S; Ninomiya T; Matsumoto S; Kanai M; Tomida S; Kiura K; Muto M; Suzawa K; Desmeules P; Kris MG; Li BT; Ladanyi M
Oncologist; 2018 Feb; 23(2):150-154. PubMed ID: 29146616
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers.
Chapman AM; Sun KY; Ruestow P; Cowan DM; Madl AK
Lung Cancer; 2016 Dec; 102():122-134. PubMed ID: 27987580
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive non-small cell lung cancers: an update for recent advances in therapeutics.
Chung C
J Oncol Pharm Pract; 2016 Jun; 22(3):461-76. PubMed ID: 25855240
[TBL] [Abstract][Full Text] [Related]
14. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
[TBL] [Abstract][Full Text] [Related]
15. Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer.
Ikeda K; Nomori H; Mori T; Sasaki J; Kobayashi T
Ann Thorac Surg; 2008 Apr; 85(4):1430-2. PubMed ID: 18355544
[TBL] [Abstract][Full Text] [Related]
16. Correlation between familial cancer history and epidermal growth factor receptor mutations in Taiwanese never smokers with non-small cell lung cancer: a case-control study.
Cheng PC; Cheng YC
J Thorac Dis; 2015 Mar; 7(3):281-7. PubMed ID: 25922704
[TBL] [Abstract][Full Text] [Related]
17. Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas.
Yamamoto H; Higasa K; Sakaguchi M; Shien K; Soh J; Ichimura K; Furukawa M; Hashida S; Tsukuda K; Takigawa N; Matsuo K; Kiura K; Miyoshi S; Matsuda F; Toyooka S
J Natl Cancer Inst; 2014 Jan; 106(1):djt338. PubMed ID: 24317180
[TBL] [Abstract][Full Text] [Related]
18. Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib.
Kosaka T; Yatabe Y; Endoh H; Yoshida K; Hida T; Tsuboi M; Tada H; Kuwano H; Mitsudomi T
Clin Cancer Res; 2006 Oct; 12(19):5764-9. PubMed ID: 17020982
[TBL] [Abstract][Full Text] [Related]
19. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.
Bell DW; Gore I; Okimoto RA; Godin-Heymann N; Sordella R; Mulloy R; Sharma SV; Brannigan BW; Mohapatra G; Settleman J; Haber DA
Nat Genet; 2005 Dec; 37(12):1315-6. PubMed ID: 16258541
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
